Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Bonanno

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
Frontiers in Oncology|February 1, 2021
Detection of Low-Frequency <i>KRAS</i> Mutations in cfDNA From <i>EGFR</i>-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase InhibitorsGiorgia Nardo, Jessica Carlet, Ludovica Marra, et al.
Anticancer Research|December 29, 2010
Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinomaLaura Bonanno, Marco Schiavon, Giorgia Nardo, et al.
Biomedicines|January 8, 2025
Immunotherapy in Non-Small-Cell Lung Cancer: A Modified Delphi Survey Consensus on First Line Treatment, Special Populations and RechallengeFrancesca Colonese, Alessandra Bulotta, Carlo Genova, et al.
Frontiers in Oncology|July 24, 2024
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysisGiulia Pasello, Alberto Pavan, Mattia De Nuzzo, et al.
Therapeutic Advances in Medical Oncology|April 12, 2018
STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancerIlaria Attili, Niki Karachaliou, Laura Bonanno, et al.
Nurse Educator|December 19, 2023
Analysis of a Needs Assessment Survey to Develop an Online Resource Repository Supporting Nurse Anesthesia EducatorsRebecca Lee, Laura Bonanno, Cormac O'Sullivan, et al.
The Oncologist|April 25, 2019
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint InhibitorsAlberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso, et al.
NPJ Precision Oncology|October 17, 2024
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancerAndrea Boscolo Bragadin, Paola Del Bianco, Elisabetta Zulato, et al.
Journal of Thoracic Disease|October 17, 2022
<i>EGFR</i> T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experienceAlessandro Dal Maso, Paola Del Bianco, Francesco Cortiula, et al.
World Journal of Surgery|January 20, 2019
Does Induction Therapy Increase Anastomotic Complications in Bronchial Sleeve Resections?Giovanni M Comacchio, Marco Schiavon, Danila Azzolina, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
Frontiers in Oncology|February 1, 2021
Detection of Low-Frequency <i>KRAS</i> Mutations in cfDNA From <i>EGFR</i>-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase InhibitorsGiorgia Nardo, Jessica Carlet, Ludovica Marra, et al.
Anticancer Research|December 29, 2010
Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinomaLaura Bonanno, Marco Schiavon, Giorgia Nardo, et al.
Biomedicines|January 8, 2025
Immunotherapy in Non-Small-Cell Lung Cancer: A Modified Delphi Survey Consensus on First Line Treatment, Special Populations and RechallengeFrancesca Colonese, Alessandra Bulotta, Carlo Genova, et al.
Frontiers in Oncology|July 24, 2024
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysisGiulia Pasello, Alberto Pavan, Mattia De Nuzzo, et al.
Therapeutic Advances in Medical Oncology|April 12, 2018
STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancerIlaria Attili, Niki Karachaliou, Laura Bonanno, et al.
Nurse Educator|December 19, 2023
Analysis of a Needs Assessment Survey to Develop an Online Resource Repository Supporting Nurse Anesthesia EducatorsRebecca Lee, Laura Bonanno, Cormac O'Sullivan, et al.
The Oncologist|April 25, 2019
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint InhibitorsAlberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso, et al.
NPJ Precision Oncology|October 17, 2024
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancerAndrea Boscolo Bragadin, Paola Del Bianco, Elisabetta Zulato, et al.
Journal of Thoracic Disease|October 17, 2022
<i>EGFR</i> T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experienceAlessandro Dal Maso, Paola Del Bianco, Francesco Cortiula, et al.
World Journal of Surgery|January 20, 2019
Does Induction Therapy Increase Anastomotic Complications in Bronchial Sleeve Resections?Giovanni M Comacchio, Marco Schiavon, Danila Azzolina, et al.
Pageof 13